GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, has entered into a strategic research collaboration with Mitsubishi Tanabe Pharma Corporation (MTPC). Under this ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of new preclinical research in Free Radical Biology and Medicine, highlighting the role of edaravone in mitigating TDP-43 ...

Dewpoint will present two posters at AACRCondensate modulators (c-mods) demonstrate robust anti-tumor effects across multiple types of ...

The ALS research landscape is evolving rapidly, with groundbreaking advancements shaping the future of therapeutic ...

Wellness Pet Company, a leader in pet nutrition for over 25 years, is returning to Global Pet Expo with new proven nutrition ...

TOKYO -- About 90% of patients with "obesity disease" in Japan perceive the medical condition as a personal responsibility, ...

Voxel51, the leading solution for building visual AI applications, today unveiled three powerful built-in workflows to streamline data curation and model analysis, enabling enterprise teams to develop ...

Akebia Therapeutics, Inc.’s AKBA share price has dipped by 22.21%, which has investors questioning if this is right time to ...

The online survey, conducted by Eli Lilly Japan K.K. and Mitsubishi Tanabe Pharma Corp. in November 2024, gathered responses from a total of 1,600 individuals including people with obesity disease ...

The company has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research ...

Heffel Fine Art Auction House hosted its highly-anticipated spring auction, showcasing more than 90 outstanding works of art to a packed sale room, buzzing with excitement. Works by Jean Paul Riopelle ...